Abbreviated Name

NOD-REGARD Ancillary Study

Lead Investigator

Chari, Suresh — The University of Texas MD Anderson Cancer Center

Coordinating Investigator

Zheng, Yingye — Fred Hutchinson Cancer Center

Involved Investigators

• — Mayo Clinic
• Fisher, William — Baylor College of Medicine
• — Kaiser Permanente Northern California
• Chari, Suresh — The University of Texas MD Anderson Cancer Center
• Wu, Bechien — Kaiser Permanente Southern California
• Zheng, Yingye — Fred Hutchinson Cancer Center

Abstract

No abstract availalbe.

Aims

No aims available.

Analytic Method

No analytic method available.

Comments

No comments available.

Outcome

No outcome available.

Secure Outcome

No secure outcome available.

Publications

• Heuriskance: a novel paradigm for systematic earlier detection of sporadic pancreatic cancer.
• RISK OF PANCREATIC CANCER IN GLYCEMICALLY DEFINED NEW-ONSET DIABETES: A PROSPECTIVE COHORT STUDY.

Biomarkers

• No biomarkers available at this time for this protocol.

Data Collections

• No data collections available at this time for this protocol.

 Team Project

Protocol ID

510

Protocol Type

Other

Fields of Research

• UNKNOWN

Collaborative Group

(No collaborative group)

Cancer Types

• Malignant neoplasm of pancreas